242 related articles for article (PubMed ID: 22001678)
1. Clinical utility of (18)F-fluoride PET/CT in benign and malignant bone diseases.
Li Y; Schiepers C; Lake R; Dadparvar S; Berenji GR
Bone; 2012 Jan; 50(1):128-39. PubMed ID: 22001678
[TBL] [Abstract][Full Text] [Related]
2. Newer PET application with an old tracer: role of 18F-NaF skeletal PET/CT in oncologic practice.
Bastawrous S; Bhargava P; Behnia F; Djang DS; Haseley DR
Radiographics; 2014; 34(5):1295-316. PubMed ID: 25208282
[TBL] [Abstract][Full Text] [Related]
3. Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT.
Even-Sapir E; Metser U; Flusser G; Zuriel L; Kollender Y; Lerman H; Lievshitz G; Ron I; Mishani E
J Nucl Med; 2004 Feb; 45(2):272-8. PubMed ID: 14960647
[TBL] [Abstract][Full Text] [Related]
4. 18F-Fluoride positron emission tomography and positron emission tomography/computed tomography.
Even-Sapir E; Mishani E; Flusser G; Metser U
Semin Nucl Med; 2007 Nov; 37(6):462-9. PubMed ID: 17920353
[TBL] [Abstract][Full Text] [Related]
5. Sodium 18F-fluoride PET/CT of bone, joint, and other disorders.
Jadvar H; Desai B; Conti PS
Semin Nucl Med; 2015 Jan; 45(1):58-65. PubMed ID: 25475379
[TBL] [Abstract][Full Text] [Related]
6. Skeletal PET with 18F-fluoride: applying new technology to an old tracer.
Grant FD; Fahey FH; Packard AB; Davis RT; Alavi A; Treves ST
J Nucl Med; 2008 Jan; 49(1):68-78. PubMed ID: 18077529
[TBL] [Abstract][Full Text] [Related]
7.
Beheshti M
PET Clin; 2018 Oct; 13(4):477-490. PubMed ID: 30219183
[No Abstract] [Full Text] [Related]
8. Atlas of sodium fluoride PET bone scans: atlas of NaF PET bone scans.
Sheth S; Colletti PM
Clin Nucl Med; 2012 May; 37(5):e110-6. PubMed ID: 22475920
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 18F fluoride PET/CT and 99mTc-MDP bone scan in the detection of skeletal metastases in urinary bladder carcinoma.
Chakraborty D; Bhattacharya A; Mete UK; Mittal BR
Clin Nucl Med; 2013 Aug; 38(8):616-21. PubMed ID: 23603596
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients.
Yen RF; Chen CY; Cheng MF; Wu YW; Shiau YC; Wu K; Hong RL; Yu CJ; Wang KL; Yang RS
Nucl Med Commun; 2010 Jul; 31(7):637-45. PubMed ID: 20389259
[TBL] [Abstract][Full Text] [Related]
11. (18)F-NaF PET/CT: EANM procedure guidelines for bone imaging.
Beheshti M; Mottaghy FM; Paycha F; Behrendt FFF; Van den Wyngaert T; Fogelman I; Strobel K; Celli M; Fanti S; Giammarile F; Krause B; Langsteger W
Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1767-1777. PubMed ID: 26201825
[TBL] [Abstract][Full Text] [Related]
12. 18F-Fluoride PET/CT for detection of bone metastasis in patients with renal cell carcinoma: a pilot study.
Sharma P; Karunanithi S; Chakraborty PS; Kumar R; Seth A; Julka PK; Bal C; Kumar R
Nucl Med Commun; 2014 Dec; 35(12):1247-53. PubMed ID: 25171438
[TBL] [Abstract][Full Text] [Related]
13. A literature review of 18F-fluoride PET/CT and 18F-choline or 11C-choline PET/CT for detection of bone metastases in patients with prostate cancer.
Wondergem M; van der Zant FM; van der Ploeg T; Knol RJ
Nucl Med Commun; 2013 Oct; 34(10):935-45. PubMed ID: 23903557
[TBL] [Abstract][Full Text] [Related]
14. Molecular imaging in oncology: (18)F-sodium fluoride PET imaging of osseous metastatic disease.
Mick CG; James T; Hill JD; Williams P; Perry M
AJR Am J Roentgenol; 2014 Aug; 203(2):263-71. PubMed ID: 25055258
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of Benign Bone Conditions on NaF-PET.
Rohren EM; Macapinlac HA
Semin Nucl Med; 2017 Jul; 47(4):392-396. PubMed ID: 28583278
[TBL] [Abstract][Full Text] [Related]
16. Dynamic bone imaging with 99mTc-labeled diphosphonates and 18F-NaF: mechanisms and applications.
Wong KK; Piert M
J Nucl Med; 2013 Apr; 54(4):590-9. PubMed ID: 23482667
[TBL] [Abstract][Full Text] [Related]
17. Spine metastases in prostate cancer: comparison of technetium-99m-MDP whole-body bone scintigraphy, [(18) F]choline positron emission tomography(PET)/computed tomography (CT) and [(18) F]NaF PET/CT.
Poulsen MH; Petersen H; Høilund-Carlsen PF; Jakobsen JS; Gerke O; Karstoft J; Steffansen SI; Walter S
BJU Int; 2014 Dec; 114(6):818-23. PubMed ID: 24314065
[TBL] [Abstract][Full Text] [Related]
18. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of clinically significant extraosseous findings on unenhanced CT portions of ¹⁸F-fluoride PET/CT bone scans.
Chen CJ; Ma SY
ScientificWorldJournal; 2012; 2012():979867. PubMed ID: 22997503
[TBL] [Abstract][Full Text] [Related]
20. Multimodal approach to detect osseous involvement in meningioma: additional value of (18)F-fluoride PET/CT for conventional imaging.
Tateishi U; Tateishi K; Hino-Shishikura A; Torii I; Inoue T; Kawahara N
Radiology; 2014 Nov; 273(2):521-8. PubMed ID: 25061831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]